Full-Time

Quality Control Technologist I-IV

Reagents

Posted on 3/27/2024

Tempus

Tempus

1,001-5,000 employees

AI-driven precision medicine analytics platform

Data & Analytics
AI & Machine Learning

Entry, Junior, Mid

Chicago, IL, USA

Required Skills
Communications
Management
Excel/Numbers/Sheets
Requirements
  • BS in medical technology, clinical laboratory science, chemical, physical or biological science
  • Prefer at least 1 year of previous experience in a molecular lab or with laboratory liquid handlers
  • Moderate experience with Microsoft Excel and/ or Google Sheets
  • Previous experience in a clinical lab regulated by CAP/ CLIA/ NYS is highly desirable
  • Good time management skills
  • Excellent communication skills
Responsibilities
  • Work within a cutting-edge genomics workflow to provide quality control support in a high-volume clinical molecular laboratory
  • Maintain CLIA/CAP compliance
  • Phase in reagents for clinical lab team processing and label reagents approved for use
  • Support Lab QC team with equipment and documentation tasks as needed
  • Document all results and findings to satisfy CLIA/CAP/NYS-DOH requirements
  • Report significant equipment findings/deviations and system deficiencies to lab management
  • Create and implement new processes for clinical lab staff
  • Update SOPs and records within the document control system
  • Create and review protocols and qualification summaries
  • Maintain reagent qualification records and manage quality control of reagent inventory
  • Interact with lab management and testing personnel to prioritize QC tasks
  • Facilitate and implement corrective and preventative actions

Tempus specializes in AI-enabled precision medicine, utilizing data and artificial intelligence to accelerate the discovery of novel targets, predict treatment effectiveness, identify clinical trials, and diagnose diseases earlier. The company's analytical machine learning platform leverages expansive clinical and molecular data to enable real-time, data-driven decisions for personalized care and targeted therapies.

Company Stage

Series G

Total Funding

$1.3B

Headquarters

Chicago, Illinois

Founded

2015

Growth & Insights
Headcount

6 month growth

6%

1 year growth

23%

2 year growth

52%
INACTIVE